Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cancers|December 30, 2025
The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic ApplicationsSabrina Busciglio, Ilenia Rita Cannizzaro, Anita Luberto, et al.
Acta Bio-Medica : Atenei Parmensis|January 8, 2020
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumabMelissa Bersanelli, Letizia Gnetti, Augusto Vaglio, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancerLeopoldo Sarli, Lorena Bottarelli, Cinzia Azzoni, et al.
Immunotherapy|February 19, 2020
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancerCecilia Bozzetti, Anna Squadrilli, Rita Nizzoli, et al.
Surgical Oncology|November 25, 2006
Loss of p27 expression and microsatellite instability in sporadic colorectal cancerLeopoldo Sarli, Lorena Bottarelli, Cinzia Azzoni, et al.
Cancers|November 13, 2021
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the LiteratureMichela Verzè, Roberta Minari, Letizia Gnetti, et al.
Oncology Reports|October 4, 2019
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancerFrancesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLCPaola Bordi, Marzia Del Re, Roberta Minari, et al.
JTO Clinical and Research Reports|February 24, 2022
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical ProofsRoberta Minari, Samuel Valentini, Denise Madeddu, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
Pageof 6